Matthew Hamilton Rosenberg’s Edwards Lifesciences EW Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.3K	Hold	357	–	–	0.01%	490
2026 Q1	$28.6K	Hold	357	–	–	0.01%	498
2025 Q4	$30.4K	Hold	357	–	–	0.01%	486
2025 Q3	$27.8K	Hold	357	–	–	0.01%	493
2025 Q2	$27.9K	Buy	+357	New	+$26.6K	0.01%	518
2024 Q4	–	Sell	-32	Closed	-$2.11K	–	819
2024 Q3	$2.11K	Hold	32	–	–	﹤0.01%	745
2024 Q2	$2.89K	Hold	32	–	–	﹤0.01%	698
2024 Q1	$3.02K	Hold	32	–	–	﹤0.01%	734
2023 Q4	$2.44K	Sell	32 -100	-76%	-$6.96K	﹤0.01%	752
2023 Q3	$9.14K	Sell	132 -13	-9%	-$1.04K	﹤0.01%	626
2023 Q2	$13.7K	Hold	145	–	–	﹤0.01%	584
2023 Q1	$12K	Hold	145	–	–	﹤0.01%	642
2022 Q4	$10.8K	Hold	145	–	–	﹤0.01%	643
2022 Q3	$12K	Buy	145 +13	+10%	+$1.25K	﹤0.01%	621
2022 Q2	$13K	Hold	132	–	–	﹤0.01%	621
2022 Q1	$16K	Hold	132	–	–	0.01%	580
2021 Q4	$17K	Buy	+132	New	+$15.4K	0.01%	542

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Matthew Hamilton Rosenberg's EW Position: Q2 2026 in Review

Matthew Hamilton Rosenberg held its Edwards Lifesciences (EW) position steady in Q2 2026 at 357 shares worth $32.3K. The position accounts for 0.01% of the portfolio, ranked #490.

Matthew Hamilton Rosenberg first reported a position in EW in Q4 2021 and has held it in 17 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Matthew Hamilton Rosenberg held 357 shares of Edwards Lifesciences worth $32.3K as of Q2 2026.
Matthew Hamilton Rosenberg left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.01% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #490 holding.
Matthew Hamilton Rosenberg first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 17 quarters since.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.